23andMe Holding Co. (ME)
NASDAQ: ME · Real-Time Price · USD
2.420
-0.320 (-11.68%)
At close: Feb 21, 2025, 4:00 PM
2.500
+0.080 (3.31%)
After-hours: Feb 21, 2025, 7:20 PM EST
23andMe Holding Co. Market Cap
23andMe Holding Co. has a market cap or net worth of $64.92 million as of February 21, 2025. Its market cap has decreased by -81.55% in one year.
Market Cap
64.92M
Enterprise Value
46.12M
1-Year Change
-81.55%
Ranking
Category
Stock Price
$2.42
Market Cap Chart
Since November 23, 2020, 23andMe Holding Co.'s market cap has decreased from $622.97M to $64.92M, a decrease of -89.58%. That is a compound annual growth rate of -41.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 64.92M | -22.69% |
| Dec 31, 2024 | 83.97M | -80.81% |
| Dec 29, 2023 | 437.66M | -55.52% |
| Dec 30, 2022 | 983.85M | -67.98% |
| Dec 31, 2021 | 3.07B | 322.89% |
| Dec 31, 2020 | 726.59M | 16.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 785.00B |
| UnitedHealth Group | 429.27B |
| Johnson & Johnson | 390.92B |
| Novo Nordisk | 370.84B |
| AbbVie | 356.85B |
| Abbott Laboratories | 234.05B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |